Mutation screening of the tau gene in patients with early-onset Alzheimer's disease
1999-12-24
Article
| Related Files |
|---|
|
Redirect to publisher's version
(publisher's version.url.txt, 47 bytes) |
Hyperphosphorylated microtubule associated protein tau, present in neurofibrillary tangles, is a prominent pathological feature of Alzheimer's disease (AD). The gene encoding tau (MAPT) was recently found mutated in frontotemporal dementia (FTD) and other tauopathies. We studied MAPT as a candidate gene in the etiology of AD. The study population consisted of 101 early-onset AD patients and 117 controls. Mutation analysis did not detect causal mutations in exons 9 to 13 encoding the microtubule-binding domains involved in FTD, however, two novel polymorphisms were detected in exon 9. Using the Ala169 polymorphism in exon 9 and a previously reported (CA)n-repeat polymorphism in intron 9, an association study was performed. No association with early-onset AD was detected. Together, our data indicate that MAPT does not play a role in early-onset AD.
- Human
- Support, Non-U.S. Gov't
- Aged
- Middle Aged
- Genotype
- DNA Mutational Analysis
- Alleles
- dementia
- Alzheimer Disease/*genetics
- tau Proteins/*genetics
- Polymorphism (Genetics)/*genetics
- 0 (tau Proteins)
- Exons/*genetics
- Introns/*genetics
